Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 832

Results For "C"

9123 News Found

Astec Lifesciences 1FY22 consolidated PAT at Rs. 12.98 Cr
News | July 29, 2021

Astec Lifesciences 1FY22 consolidated PAT at Rs. 12.98 Cr

The company posted net profit of Rs.16.18 crores for the period ended June 30, 2020.


Pfizer posts Q1FY22 PAT of Rs. 199.91 Cr
News | July 29, 2021

Pfizer posts Q1FY22 PAT of Rs. 199.91 Cr

The company posted net profit of Rs.124.45 crores for the period ended June 30, 2020.


Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr
News | July 28, 2021

Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr

The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.


Granules India Q1FY22 consolidated net profit at Rs. 120.20 Cr
News | July 28, 2021

Granules India Q1FY22 consolidated net profit at Rs. 120.20 Cr

The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.


Bharat Immunologicals and Biologicals Corporation Q1FY22 net profit at Rs. 1.92 Cr
News | July 28, 2021

Bharat Immunologicals and Biologicals Corporation Q1FY22 net profit at Rs. 1.92 Cr

The company reported total income Rs.18.57 crores during the period ended June 30, 2020.


Torrent Pharmaceuticals Q1FY22 consolidated PAT up at Rs. 330 Cr
News | July 28, 2021

Torrent Pharmaceuticals Q1FY22 consolidated PAT up at Rs. 330 Cr

The company posted net profit of Rs.321 crores for the period ended June 30, 2020.


Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 Cr
News | July 28, 2021

Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 Cr

The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.


Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr
News | July 28, 2021

Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr

The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.


Hugely successful vaccination roll out made possible by India-UK partnership
Policy | July 28, 2021

Hugely successful vaccination roll out made possible by India-UK partnership

The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector


Morepen to start Sputnik V Vaccine commercial production in 4-6 weeks
News | July 28, 2021

Morepen to start Sputnik V Vaccine commercial production in 4-6 weeks

The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval